Harmony Biosciences Holdings, Inc. (HRMY)

Last Closing Price: 27.04 (2025-09-25)

Net Income (Quarterly)

Net Income: Company's net profit or loss after all revenues, income items, and expenses have been accounted for. Because this figure is given after preferred dividend expense, it is the net income value allotted to common shareholders.

Harmony Biosciences Holdings, Inc. (HRMY) had Net Income of $39.78M for the most recently reported fiscal quarter, ending 2025-06-30.

Figures for fiscal quarter ending 2025-06-30
Income Statement Financials
$200.49M
Net Income
$39.78M
$38.15M
$162.34M
$152.31M
$48.18M
$1.46M
$49.64M
$49.64M
$39.78M
$39.78M
$39.78M
$39.78M
$48.18M
$53.86M
57.47M
58.43M
$0.69
$0.68
Balance Sheet Financials
$691.35M
$1.38M
$416.65M
$1.11B
$180.13M
$153.34M
$154.79M
$334.93M
$773.08M
$671.74M
$773.08M
57.54M
Cash Flow Statement Financials
$113.31M
$-17.23M
$-3.04M
$453.27M
$546.32M
$93.05M
$23.95M
--
--
Fundamental Metrics & Ratios
3.84
--
--
0.17
0.22
80.97%
24.03%
24.03%
--
24.76%
19.84%
$113.18M
--
--
--
0.18
6.25
2.16
41.74
5.15%
5.92%
3.59%
4.29%
$13.44
$1.94
$1.94